Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats

Neuroscience
A E PollackJ S Fink

Abstract

Chronic treatment with dopaminergic agonists is associated with response fluctuations to L-dihydroxyphenylalanine in Parkinson's disease and enhanced motor activity to D1 and D2 dopamine agonists in rats with 6-hydroxydopamine lesions of the nigrostriatal pathway. In dopamine-depleted rodents this phenomenon has been referred to as "priming" or reverse tolerance. The neurochemical changes that underlie "priming" of dopaminergic agonist responses are poorly understood. Some aspects of priming of D1 agonist-mediated rotation in the 6-hydroxydopamine-lesioned rat have been characterized, but priming of D2-agonist-dependent motor responses has been less thoroughly studied. In this study, examination of rotational behaviour and induction of Fos-like immunoreactivity were used to investigate changes in the striatal outflow systems in response to treatment with the D2 agonist quinpirole in 6-hydroxydopamine-lesioned rats that had been primed with apomorphine. Administration of apomorphine (0.5 mg/kg; three injections at three to six day intervals) permitted an otherwise inactive dose of quinpirole (0.25 mg/kg) to produce robust contralateral rotation and to induce the expression of Fos in striatal neurons belonging to the striato-nigr...Continue Reading

References

Sep 1, 1992·Brain Research. Molecular Brain Research·K R PennypackerJ S Hong
Nov 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·D J SurmeierS T Kitai
Feb 11, 1992·Trends in Pharmacological Sciences·D R Sibley, F J Monsma
Mar 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·D M WeinerM R Brann
May 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·C Le MoineB Bloch
Sep 18, 1990·Neuroscience Letters·C Le MoineB Bloch
May 16, 1990·European Journal of Pharmacology·M MorelliG Di Chiara
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·A M GraybielH A Robertson
Jul 23, 1990·Brain Research·G S RobertsonH C Fibiger
Jan 1, 1990·Movement Disorders : Official Journal of the Movement Disorder Society·S BoyceA R Crossman
Jan 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·C Le MoineB Bloch
Oct 1, 1989·Trends in Neurosciences·R L AlbinJ B Penney
Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·J H Meador-WoodruffO Civelli
Mar 21, 1989·European Journal of Pharmacology·M MorelliG Di Chiara
Aug 14, 1989·FEBS Letters·D M Weiner, M R Brann
Mar 14, 1987·Lancet·C E ClarkeA R Crossman
Oct 8, 1986·Brain Research·G S Robertson, H A Robertson
Jul 1, 1987·Annals of Neurology·G J de JongP I Schmitz
Jul 1, 1995·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·K D BurrisP B Molinoff

❮ Previous
Next ❯

Citations

Jun 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·K AlvaresJ K Reddy
Oct 1, 1967·The Journal of Cell Biology·D SvobodaD Azarnoff
Aug 1, 1969·The Journal of Cell Biology·M E Beard, A B Novikoff
Jun 1, 1984·The Journal of Cell Biology·J K ReddyN D Lalwani
Feb 1, 1971·Plant Physiology·R R Theimer, H Beevers
Aug 26, 1998·Reviews in the Neurosciences·E BezardC E Gross
Apr 23, 2009·Neurotoxicity Research·M L GregórioC Da Cunha
May 19, 2000·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·I Cantuti-CastelvetriJ A Joseph
Oct 6, 2009·Pharmacology, Biochemistry, and Behavior·Alexia E Pollack, Lindsay I Thomas
Jul 22, 2008·Behavioural Brain Research·Celia LarramendyOscar S Gershanik
Sep 11, 2007·European Journal of Pharmacology·Jocelien D A OlivierJan G Veening
Oct 15, 2021·CNS Drugs·Sarah MarmolJason Margolesky

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.